check ALZ-801 for those who want to do DD and not keep your head buried in the sand. Here we are talking about a pill, PM flagging APOE 4, phase 2 completed with 2 year data, phase 3 325 ptsTLR expected end of 2024.
No ARIA and reduction in tau, some positive cognition gain, other biomarkers tested.
BTW, Alzheon is not a publicly traded company
Again I state...we need Rett and we need it now, complete and unambiguous.
Market Data 
Markets 
AI
